Navigation Links
Ultrasound improves stem cell transplants
Date:9/6/2011

Transplantation of haematopoietic stem cells is an effective treatment for patients with malignant blood diseases. The composition and quality of the transplanted cells are crucial to the outcome. Researchers from Lund University, Sweden, have now developed a method to improve the quality of the transplanted cells using ultrasound for cell separation.

For patients with blood cancer, a blood stem cell transplant is often the only treatment that can cure the disease. The quality of the transplanted blood stem cells and the choice and composition of the transplanted cells can be crucial.

Current methods of collecting and processing stem cell products leave a lot to be desired. Recent results from Lund University indicate that it may be possible to considerably improve the quality of the blood stem cell product by using a method known as acoustic cell separation.

"The method was developed in the field of microtechnology and builds on basic engineering research from Lund University", explains Professor Thomas Laurell, research group leader at the Faculty of Engineering. The method is expected to facilitate improvements in the processing of blood stem cells.

Associate Professor Stefan Scheding, senior consultant at the Department of Haematology at Skne University Hospital and research group leader at the Stem Cell Centre at Lund University, is in charge of the preclinical development of the new method, which aims to effectively separate and possibly remove or concentrate cell populations which are normally found in standard blood stem cells products. The first step has been to show that the method works, by separating out platelets from stem cell products.

"Our hope is that it will become possible to produce the optimal stem cell product for each individual transplant patient", says Stefan Scheding. "This would give us a good chance of improving the treatment of patients who would otherwise be at risk of suffering from serious transplant complications, such as graft-versus-host disease* and infections. By optimising the quality of the transplanted cells, it may even be possible to better fight the leukaemia cells that remain in the body despite the transplant treatment", he explains.


'/>"/>

Contact: Thomas Laurell
Thomas.Laurell@elmat.lth.se
46-462-227-540
Lund University
Source:Eurekalert

Related medicine news :

1. Ultrasound of Neck Arteries May Help Gauge Stroke Risk
2. Abnormal brain ultrasounds in premature infants indicate future risk of psychiatric disorders
3. Ultrasound May Determine Heart Attack Risk in HIV Patients
4. New technology fuses MRI, ultrasound to achieve targeted biopsy of prostate cancer
5. Ultrasound combined with pre-operative MRI is cost effective in evaluating rotator cuff tears
6. Bedside ultrasound becomes a reality
7. Microbubble ultrasound and breast biopsies
8. Ultrasound and a blood test can increase survival after myocardial infarction
9. AIUM announces ultrasound practice accreditation in fetal echocardiography
10. AIUM spearheads collaboration to develop guidelines for point-of-care ultrasound applications
11. Accurate diagnosis of prostate cancer with ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: